Large-scale testing (Phase 3)Looking for participantsNCT07525206
What this trial is testing
Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer
AbbVie 990